CIK 0000715446 · Non-accelerated filer<br>Smaller reporting company
Anixa Biosciences Inc
Sign in to watch- Ticker
- ANIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Oct 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 112622630
- Phone
- 408-708-9808
- Business address
- 3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE, CA, 95118
- Former names
- ITUS Corp, COPYTELE INC
- 8-K Event Regulation FD disclosure
- 8-K Event Material agreement
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- 10-Q Report Quarterly Report
- S-3 Offering Registration Statement
- 8-K Event Regulation FD disclosure
- 4 Other acquisition COO & CFO acquired 800 shares (other)
- 4 Open-market buy Director bought 900 shares at $4.22 ($3,798)
- 4 Open-market buy Director bought 2,000 shares at $4.21 ($8,420)
- 4 Open-market buy Chief Executive Officer bought 4,000 shares at $4.21 ($16,840)
- 4 Open-market buy Director bought 10,000 shares at $4.28 ($42,800)
- 4 Open-market buy Chief Executive Officer bought 10,000 shares at $4.27 ($42,700)
- 4 Open-market buy Director bought 50,000 shares at $4.09 ($204,500)
- 10-Q Report Quarterly Report
- 8-K Event Other events
- 10-K Report Annual Report
- SC 13D/A Stake Beneficial Ownership Report
- 4 Open-market buy Director bought 2,000 shares at $4.05 ($8,100)
Page 14 of 50 · 983 filings